
Global Monitor: Contraceptive Watch: FDA Delays Approval of Abortion Pill
Dr. Wilke’s Questions Cause RU-486 Advocates to Retreat The US Federal Drug Administration (FDA) handed pro-abortion activists a major setback last February when it delayed the approval of RU-486 (cytotec prostaglandin), the so-called “abortion pill.” In a short statement, the FDA said that there were